Who we are
We are a team of clinicians dedicated to providing compassionate, evidence-informed cannabis and psychedelic-assisted therapy within a safe, grounded, and relational framework. Our work is rooted in trauma-responsive care, cultural humility, and a deep respect for each client’s inner healing intelligence.
Together, we create supportive spaces for exploration, insight, and transformation. Whether guiding clients through preparation, facilitating therapeutic experiences, or offering thoughtful integration, we approach this work with intention, integrity, and attunement. Each member of our team brings unique expertise in psychotherapy, harm reduction, and integrative mental health, allowing us to meet clients with the individualized care they deserve.
We believe healing unfolds when science, connection, and personal agency intersect. Our mission is to walk alongside clients—steadily, respectfully, and without judgment—as they navigate expanded states of consciousness, deepen self-understanding, and move toward greater balance, clarity, and wholeness.
Alison Draisin, PsyD, LMHC holds a Master’s Degree in Art Psychotherapy and a Doctorate in Clinical Psychology and has worked in the mental health field for more than three decades. Her clinical focus centers on integrative, trauma-informed care, with specialized expertise in cannabis and psychedelic-assisted psychotherapy.
In 2018, Dr. Draisin joined the Advanced Integrative Medical Science (AIMS) Institute in Seattle, where she provided psychotherapy and contributed to research in cannabis and psychedelic medicine. At AIMS, she served as Lead Psychotherapist and Director of Ketamine-Assisted Psychotherapy Provider Training, supervising and mentoring clinicians as they developed competency in psychedelic-assisted therapeutic modalities.
Dr. Draisin is currently on faculty with the Synaptic Institute, a psychedelic-assisted therapy training program approved by the Oregon Health Authority. She is also a certified Psilocybin Facilitator through Synaptic, expanding her work into regulated psilocybin services and practitioner education.
Nationally and internationally recognized for her contributions to the cannabis and psychedelic fields, Dr. Draisin was the founder and director of Ettalews Edibles (est. 2009), an award-winning medical cannabis edibles company. Her reputation in the industry led to invitations to judge non-solvent hash for High Times and other cannabis competitions worldwide, as well as opportunities to speak at conferences across the globe on both cannabis and psychedelics.
A long-standing advocate for women in the industry, Dr. Draisin was a founding member of Women of Weed, a social organization dedicated to supporting and empowering women working in cannabis. She continues to mentor women entering or expanding their roles in the cannabis and psychedelic space.
Dr. Draisin also served as President of the Board of Directors for the Center for Cannabis and Social Policy (CASP), reflecting her ongoing commitment to education, advocacy, and ethical policy development within emerging therapeutic fields.
Kylo Ren has been a service animal since 2021, with clients who want animal assisted support during their journeys.
Contact us
Interested in working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!